As GLP-1 medications like semaglutide gain popularity for weight management, questions are emerging around their role in menopause care. This session will examine how these therapies intersect with hormonal changes, and what clinicians should consider when prescribing them to women in perimenopause or menopause. We will discuss emerging research, considerations for long-term use, and what to watch for when it comes to bone health, muscle mass, cardiovascular risk, and overall patient outcomes.